In our model, we observe that about 49% of the population of exposed mice develop symptoms of insulin resistance and metabolic syndrome, with increases in fasting blood glucose, fasting serum insulin, and HOMA-IR index, leading to ectopic accumulation of fat in the viscera. The gene discussed is INS; the disease is metabolic syndrome.